This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tugizov, S.
Right arrow Articles by Palefsky, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tugizov, S.
Right arrow Articles by Palefsky, J.

 Previous Article  |  Next Article 

Journal of Virology, January 2005, p. 1099-1112, Vol. 79, No. 2
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.2.1099-1112.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Inhibition of Human Papillomavirus Type 16 E7 Phosphorylation by the S100 MRP-8/14 Protein Complex

Sharof Tugizov,1,2* Jennifer Berline,1 Rossana Herrera,1 Maria Elena Penaranda,2,{dagger} Mayumi Nakagawa,3 and Joel Palefsky1,2

Department of Medicine,1 Department of Stomatology, University of California, San Francisco, San Francisco, California,2 Department of Dermatology, University of Arkansas, Little Rock, Arkansas3

Received 5 July 2004/ Accepted 30 August 2004

The human papillomavirus type 16 (HPV16) E7 is a major viral oncoprotein that is phosphorylated by casein kinase II (CKII). Two S100 family calcium-binding proteins, macrophage inhibitory-related factor protein 8 (MRP-8) and MRP-14, form a protein complex, MRP-8/14, that inactivates CKII. The MRP-8/14 protein complex may inhibit CKII-mediated E7 phosphorylation and therefore may alter its interaction with cellular ligands and reduce E7 oncogenic activity. We examined the inhibitory effect of the MRP-8/14 complex on CKII activity and HPV16 E7 phosphorylation. We have shown that CKII activity and HPV16 E7 phosphorylation were inhibited by uptake of exogenous MRP-8/14 and activation of endogenous MRP-8/14. MRP-8/14-mediated inhibition of E7 phosphorylation occurred at the G1 phase of the cell cycle. Analysis of MRP expression in primary keratinocytes and in HPV16- and 18-transformed cervical and foreskin epithelial cell lines showed that expression of MRP-8, MRP-14, and the MRP-8/14 complex was detected only in primary untransformed keratinocytes and not in the HPV-infected immortalized epithelial cells. CKII activity in HPV-immortalized keratinocytes was approximately fourfold higher than in HPV-negative primary keratinocytes. Treatment of HPV-positive immortalized epithelial cells with exogenous MRP-8/14 resulted in E7 hypophosphorylation and complete inhibition of cell growth within 2 weeks, compared with HPV-negative primary and immortalized HPV-negative cervical epithelial cells, which showed 25 and 40% growth inhibition, respectively. Together these results suggests that the MRP-8/14 protein complex in HPV-infected epithelial cells may play an important role in regulation of CKII-mediated E7 phosphorylation and inhibition of its oncogenic activity.

* Corresponding author. Mailing address: Department of Medicine, University of California, San Francisco, 513 Parnassus Ave., San Francisco, CA 94143. Phone: (415) 514-3177. Fax: (415) 476-9364. E-mail: tugizov{at}itsa.ucsf.edu.

{dagger} Present address: Sustainable Sciences Institute, San Francisco, CA 94102.

Journal of Virology, January 2005, p. 1099-1112, Vol. 79, No. 2
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.2.1099-1112.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Endoh, Y., Chung, Y. M., Clark, I. A., Geczy, C. L., Hsu, K. (2009). IL-10-Dependent S100A8 Gene Induction in Monocytes/Macrophages by Double-Stranded RNA. J. Immunol. 182: 2258-2268 [Abstract] [Full Text]  
  • Dell'Oste, V., Azzimonti, B., Mondini, M., De Andrea, M., Borgogna, C., Mesturini, R., Accardi, R., Tommasino, M., Landolfo, S., Dianzani, U., Gariglio, M. (2008). Altered expression of UVB-induced cytokines in human papillomavirus-immortalized epithelial cells. J. Gen. Virol. 89: 2461-2466 [Abstract] [Full Text]  
  • Treharne, K. J., Crawford, R. M., Xu, Z., Chen, J.-H., Best, O. G., Schulte, E. A., Gruenert, D. C., Wilson, S. M., Sheppard, D. N., Kunzelmann, K., Mehta, A. (2007). Protein Kinase CK2, Cystic Fibrosis Transmembrane Conductance Regulator, and the {Delta}F508 Mutation: F508 DELETION DISRUPTS A KINASE-BINDING SITE. J. Biol. Chem. 282: 10804-10813 [Abstract] [Full Text]  
  • Sroussi, H. Y., Berline, J., Palefsky, J. M. (2007). Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro. J. Leukoc. Biol. 81: 818-824 [Abstract] [Full Text]  
  • Sroussi, H.Y., Berline, J., Dazin, P., Green, P., Palefsky, J.M. (2006). S100A8 Triggers Oxidation-sensitive Repulsion of Neutrophils. JDR 85: 829-833 [Abstract] [Full Text]  
  • McCormick, M. M., Rahimi, F., Bobryshev, Y. V., Gaus, K., Zreiqat, H., Cai, H., Lord, R. S. A., Geczy, C. L. (2005). S100A8 and S100A9 in Human Arterial Wall: IMPLICATIONS FOR ATHEROGENESIS. J. Biol. Chem. 280: 41521-41529 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»